首页> 外文期刊>Perspectives in vascular surgery and endovascular therapy. >Clinical outcome of staged versus combined treatment approach of hybrid repair of thoracoabdominal aortic aneurysm with visceral vessel debranching and aortic endograft exclusion
【24h】

Clinical outcome of staged versus combined treatment approach of hybrid repair of thoracoabdominal aortic aneurysm with visceral vessel debranching and aortic endograft exclusion

机译:分期与联合治疗方法联合胸腹主动脉瘤与内脏血管脱支和主动脉内移植排斥的联合治疗方法的临床结果

获取原文
获取原文并翻译 | 示例
       

摘要

Although visceral vessel debranching and endovascular aneurysm exclusion represents a hybrid treatment approach in patients with thoracoabdominal aortic aneurysm, the effect of timing with regard to the visceral debranching procedure and endovascular aneurysm exclusion in this treatment strategy remains unclear. In this study, the authors analyzed their recent institutional experience of visceral debranching and aneurysm stent-grafting procedures. Specifically, the authors compared the effect of staged (n = 27) versus combined (n = 31) hybrid treatment in patients with complex aortic aneurysms. This study showed a higher incidence of renal insufficiency in patients undergoing a combined hybrid repair than the staged hybrid approach. The possibility of aneurysm rupture may exist in the staged treatment approach if the duration of staged repair is prolonged. The combined hybrid treatment strategy should be performed with caution as it is associated with significantly higher complication rates than the staged hybrid treatment modality.
机译:尽管对胸腹主动脉瘤患者采用内脏血管分支和排除血管内动脉瘤是一种混合治疗方法,但是在这种治疗策略中,内脏去分支程序和血管内动脉瘤排除的时机影响尚不清楚。在这项研究中,作者分析了他们最近的内脏去分支和动脉瘤支架移植程序的机构经验。特别是,作者比较了分期(n = 27)与联合(n = 31)混合治疗对复杂主动脉瘤患者的疗效。这项研究表明,进行联合混合修复的患者肾功能不全的发生率要高于阶段混合方法。如果分阶段修复的时间延长,则在分阶段治疗方法中可能存在动脉瘤破裂的可能性。联合的混合治疗策略应谨慎进行,因为与分阶段的混合治疗方式相比,它具有更高的并发症发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号